Switching clotting factor products did not cause new inhibitors (neutralizing antibodies that can prevent the treatment from working) to develop…
Articles by Margarida Maia, PhD
Recognizing acquired hemophilia A (AHA) early and ordering simple blood clotting tests in older patients with unexplained bruising or…
Once-weekly infusions of Altuvoct (efanesoctocog alfa) — a long-lasting hemophilia treatment marketed in the U.S. as Altuviiio —…
A new type of gene-editing treatment being developed by researchers in Japan corrected mutations causing severe hemophilia B in…
At the World Health Assembly (WHA), member states of the World Health Organization (WHO) unanimously adopted a resolution on…
In the large clinical trial that supported the 2024 approval of Hympavzi (marstacimab) for adults and children with…
The one-time gene therapy BBM-H901 (dalnacogene ponparvovec) has been officially approved in the Macao region of China for the treatment…
Many boys and young men with hemophilia regularly participate in sports. However, doing so frequently — particularly three or…
In boys and men with severe hemophilia A, starting prophylaxis — preventive treatment given regularly to reduce bleeding —…
Testing levels of thrombin — an enzyme that helps blood clot — in people with acquired hemophilia A could…